This question has been answered by the relevant Government Department.
Question text
Baroness Ritchie of Downpatrick to ask His Majesty's Government what assessment they have made of the monoclonal antibody Nirsevimab, which was approved by the Medicines and Healthcare products Regulatory Agency in November 2022; and when it will be made available to patients on the NHS. HL4680
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.
Main Member
Baroness Ritchie of Downpatrick
Labour
Life peer